BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17459055)

  • 21. Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma.
    Filipits M; Drach J; Pohl G; Schuster J; Stranzl T; Ackermann J; Königsberg R; Kaufmann H; Gisslinger H; Huber H; Ludwig H; Pirker R
    Clin Cancer Res; 1999 Sep; 5(9):2426-30. PubMed ID: 10499614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species.
    Evdokimova V; Ruzanov P; Anglesio MS; Sorokin AV; Ovchinnikov LP; Buckley J; Triche TJ; Sonenberg N; Sorensen PH
    Mol Cell Biol; 2006 Jan; 26(1):277-92. PubMed ID: 16354698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
    Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
    Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
    Faried LS; Faried A; Kanuma T; Aoki H; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
    Mol Carcinog; 2008 Jun; 47(6):446-57. PubMed ID: 18058806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
    Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
    Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma.
    Lu D; Shi HC; Wang ZX; Gu XW; Zeng YJ
    Br J Biomed Sci; 2011; 68(2):69-74. PubMed ID: 21706917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
    Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?
    Kamura T; Yahata H; Amada S; Ogawa S; Sonoda T; Kobayashi H; Mitsumoto M; Kohno K; Kuwano M; Nakano H
    Cancer; 1999 Jun; 85(11):2450-4. PubMed ID: 10357417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
    Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
    FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells.
    Guo Z; Cai S; Fang R; Chen H; Du J; Tan Y; Ma W; Hu H; Cai S; Liu Y
    Colloids Surf B Biointerfaces; 2007 Oct; 60(1):1-6. PubMed ID: 17601710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
    Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.
    Yi X; Zhou Y; Zheng W; Chambers SK
    Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):93-8. PubMed ID: 19281587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunohistochemical expression of integrin alphav, beta5 and beta3 in ovarian epithelial carcinoma: correlation with drug resistance of chemotherapy].
    Guo HY; Han JS; Zhang LF; Wang LN; Geng L; Chen GA
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):750-3. PubMed ID: 15634501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
    Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
    J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of the resistance proteins LRP, Pgp, MRP1, MRP3, and MRP5 in epithelial ovarian cancer.
    Sedláková I; Laco J; Caltová K; Červinka M; Tošner J; Řezáč A; Špaček J
    Int J Gynecol Cancer; 2015 Feb; 25(2):236-43. PubMed ID: 25594141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the lung resistance protein in primary colorectal carcinomas.
    Pohl G; Suchomel RW; Stranzl T; Depisch D; Stiglbauer W; Filipits M; Pirker R
    Anticancer Res; 2001; 21(1A):201-4. PubMed ID: 11299735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men.
    Shimizu Y; Segawa T; Inoue T; Shiraishi T; Yoshida T; Toda Y; Yamada T; Kinukawa N; Terada N; Kobayashi T; Kinoshita H; Kamoto T; Nakamura E; Ogawa O
    BJU Int; 2007 Sep; 100(3):685-90. PubMed ID: 17542985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
    Yang Y; Yang H; McNutt MA; Xiong F; Nie X; Li L; Zhou R
    Oncol Rep; 2008 Nov; 20(5):1077-83. PubMed ID: 18949404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.